arrow
J

Jingao Li

second affiliated hospital of nanchang medical college
H指数:27
被引数:5,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Overlap-adapted Subvolume Prescription to Reduce Temporal Lobe Injury Risk in T4 Nasopharyngeal Carcinoma: A Prospective Cohort Study with a Contemporaneous Comparator

重叠适配子体积处方以降低T4鼻咽癌患者颞叶损伤风险:一项具有同期对照的前瞻性队列研究

2026-08-210
OAAI
Retraction notice to “Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway” [Cellular Signalling 56 (2019) 1–14]

撤稿声明针对“低表达PDK1通过抑制PI3K-PDK1-Akt通路抑制肾细胞癌细胞增殖、迁移、侵袭和上皮-间质转化”[Cellular Signalling 56 (2019) 1–14]

2026-04-170
PRE
Effects of Nutritional Interventions on Quality of Life in Patients with Nasopharyngeal Carcinoma Undergoing Radiotherapy Based on Dynamic Nutritional Risk Screening and Assessment: An Open-label Single-center Randomized Phase 3 Trial

基于动态营养风险筛查与评估的鼻咽癌放疗患者营养干预对生活质量的影响:一项开放标签单中心随机III期试验

2025-11-290
OAAI
Reducing radiation-induced hypothyroidism by modified delineation of cervical lymphatic drainage area for nasopharyngeal carcinoma treated by intensity-modulated radiation Therapy: 3 years' experience

改良颈部淋巴引流区勾画减轻鼻咽癌调强放疗所致甲状腺功能减退3年经验

2025-03-010
PRE
Efficacy and optimal duration of maintenance immunotherapy following systemic chemoimmunotherapy and locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A multicenter retrospective cohort study

系统性化学免疫治疗和局部区域放疗对转移性鼻咽癌的疗效和维持免疫治疗的最佳持续时间: 一项多中心回顾性队列研究

2025-02-010
PRE
The pharmacogenomic landscape in the Chinese: An analytics of pharmacogenetic variants in 206,640 individuals

中国人的药物基因组学图谱:对206,640名个体中药物遗传变异的分析

2025-02-010
OAAI
Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma The JUPITER-02 Randomized Clinical Trial

Toripalimab联合化疗治疗复发性或转移性鼻咽癌JUPITER-02随机临床试验

2023-11-2852
OA